KUALA LUMPUR, Nov 7 (Bernama) -- Coherus BioSciences, Inc. (Nasdaq:CHRS) announced today the pricing of its initial public offering of 6,296,300 shares of its common stock at a public offering price of $13.50 per share, before underwriting discounts, commissions and estimated expenses. All of the shares of common stock are being offered by Coherus. The Company's common stock has been approved for listing on the NASDAQ Global Market and is expected to begin trading today under the ticker symbol "CHRS". In addition, Coherus has granted the underwriters a 30-day option to purchase up to 944,445 additional shares of common stock at the offering price. The offering is expected to close on November 12, 2014, subject to customary closing conditions.
|
Monday, November 10, 2014
COHERUS BIOSCIENCES PRICES INITIAL PUBLIC OFFERING OF $85 MILLION OF COMMON STOCK
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment